NLRP3 and pyroptosis blockers for treating inflammatory diseases
Rebecca C. Coll, Kate Schroder, Pablo Pelegrín Highlights The nucleotide-binding oligomerization domain, leucine-rich repeat and pyrin domain-containing protein 3 (NLRP3) inflammasome is a key mediator of pathological inflammation in many diseases. There are several drug-like small molecules under clinical development as novel therapeutics targeting the NLRP3 inflammasome. Pyroptosis is a unique approach to suppress chronic […]
NLRP3 and pyroptosis blockers for treating inflammatory diseases Leer más »